QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
BATS:RCOM

Elkhorn Fundamental Commodity Strat ETF (RCOM) Price, Holdings, & News

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free RCOM Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$28.34
▼
$28.34
50-Day Range
N/A
52-Week Range
$24.20
▼
$30.06
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
Assets Under Management
$12.75 million
Dividend Yield
N/A
Net Expense Ratio
0.75%
Stock Analysis
Stock Analysis

RCOM ETF News Headlines

April 11, 2024 | nasdaq.com
What are Spot Ethereum ETFs and Will They be Approved?
December 28, 2023 | wsj.com
Bitwise Ethereum Strategy ETF
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
November 22, 2023 | finance.yahoo.com
Elkhorn Fundamental Commodity Strat ETF (RCOM)
November 17, 2023 | msn.com
BlackRock files spot Ethereum ETF application with the SEC: CNBC Crypto World
November 2, 2023 | markets.businessinsider.com
Inverse Ethereum Futures ETF Could Awaken Bearish Investors
October 30, 2023 | investing.com
FTGC ETF Stock Price History
October 26, 2023 | wsj.com
VanEck Ethereum Strategy ETF
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
October 20, 2023 | markets.businessinsider.com
New Ethereum (ETH) ETFs Hit the Market. Are They Worth Buying?
See More Headlines
Receive RCOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elkhorn Fundamental Commodity Strat ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Elkhorn
Fund Name
Elkhorn Fundamental Commodity Strategy ETF
Tax Classification
Regulated Investment Company
Stock Exchange
BATS
Current Symbol
BATS:RCOM
Inception Date
9/21/2016
Fund Manager
Benjamin Fulton, Jeff Wynsma, Jordan Golz, Derek Babb
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Commodities
Benchmark
N/A
Category
Broad Commodities
Focus
Broad Commodities
Development Level
Blended Development
Region
Global
Number of Holdings
0

Fund Statistics

Assets Under Management
$12.75 million
Average Daily Volume
$2,169.00
Discount/Premium
-0.07%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Elkhorn Investments, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Outstanding Shares
N/A
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

Elkhorn Fundamental Commodity Strat ETF Expenses

TypeRCOMBroad Commodities ETFsCommodities ETFsBATS ETFsAll ETFs
Management Fee0.75%0.61%0.66%0.56%0.51%
Other Expenses0.00%0.13%0.27%0.51%0.58%
Total Expense0.75%0.68%0.77%0.68%0.70%
Fee Waiver0.00%-0.13%-0.18%-0.34%-0.57%
Net Expense0.75%0.62%0.70%0.63%0.58%

Elkhorn Fundamental Commodity Strat ETF (RCOM)

Full Holdings Details

RCOM ETF - Frequently Asked Questions

What does RCOM invest in?

Elkhorn Fundamental Commodity Strat ETF is a commodities fund issued by Elkhorn. RCOM focuses on broad commodities investments. The fund's investments total to approximately $12.75 million assets under management.

What is the management fee for Elkhorn Fundamental Commodity Strat ETF?

Elkhorn Fundamental Commodity Strat ETF's management fee is 0.75% and has no other recorded expenses or fee waivers. The net expense ratio for RCOM is 0.75%.

This page (BATS:RCOM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media